Literature DB >> 1080690

Different sites of membrane action for tetrodotoxin and lipid-soluble anesthetics.

A L Staiman, P Seeman.   

Abstract

1. To examine whether different local anesthetics act on different or similar sites in the nerve membrane, the effects of combinations of lipid-soluble anesthetics and tetrodotoxin (TTX) were studied on the compound action potential of the frog sciatic nerve. 2. The nerve-blocking potency of TTX was potentiated 5-fold by benzyl alcohol and 10-fold by lidocaine, at concentrations of these latter two drugs which were just barely anesthetic; no such synergism occurred between saxitoxin (STX) and TTX, their combined effect being merely additive. 3. Simple additive effects also occurred between benzyl alcohol and phenol, benzyl alcohol and urethane, as well as lidocaine with a spirosuccinimide, RAC 109 II. 4. Synergism occurred between STX and 2-aminobenzimidazole. 5. A small but consistent synergism occurred between lidocaine and benzyl alcohol. 6. It is concluded that uncharged anesthetics, tertiary amines, and TTX act via different membrane binding sites which are all closely associated with the Na+ conductance channels.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080690     DOI: 10.1139/y75-073

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  3 in total

1.  Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids.

Authors:  W R Leifert; E J McMurchie; D A Saint
Journal:  J Physiol       Date:  1999-11-01       Impact factor: 5.182

2.  Saxitoxin and procaine act independently on separate sites of the sodium channel.

Authors:  H H Wagner; W Ulbricht
Journal:  Pflugers Arch       Date:  1976-06-29       Impact factor: 3.657

3.  Topical drug formulations for prolonged corneal anesthesia.

Authors:  Liqiang Wang; Sahadev A Shankarappa; Rong Tong; Joseph B Ciolino; Jonathan H Tsui; Homer H Chiang; Daniel S Kohane
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.